WST
West Pharmaceutical Services, Inc.
Dividend Growth | |
Min. Div. Growth Past 7 Yrs. ≥ 15%: 5.7% | |
Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 5.7% | |
Years of Div. Growth ≥ 15: 37 | |
Income Generation | |
Current Yield 0.3% ≥ 20-Yrs Treasury Yield 4.7% | |
Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs | |
Sustainability | |
Debt-To-Equity 0.10 ≤ 0.45 | |
Last 12Months Cash Payout 0.15 ≤ 0.6 | |
Profitability | |
5-Yr Avg. Return-on-Equity 22.5% ≥ 15% | |
Last 12Months Return-on-Equity 20.4% ≥ 15% | |
Last 12Months Net Profit Margin 19.4% ≥ 10% | |
Fair Value | |
Average 5-Yrs High Yield 0.4% | |
Current Price $314.5 ≤ High Yield Price $191.6 | |
Average 5-Yrs Price-to-Earning (P/E) 41.9 | |
Current Price $314.5 ≤ Average P/E Price $317.7 | |
Current Price $314.5 ≤ Fair Value $196.3 |
Company Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Dividend
Revenue
Earning
Free Cash Flow